The causal association between COVID-19 and herpes simplex virus: a Mendelian randomization study.

COVID-19 Mendelian randomization association causal effect herpes simplex virus

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 22 08 2023
accepted: 28 11 2023
medline: 26 12 2023
pubmed: 26 12 2023
entrez: 26 12 2023
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) has emerged as a main global public health challenge. Additionally, herpes simplex virus type-1 (HSV-1) and type 2 (HSV-2) are widespread viruses that can cause orolabial herpes and genital herpes. Several clinical case reports have declared a possible association between the two, however, the causal relationship between them has not been clarified. This study utilized a Mendelian randomization (MR) approach for causality assessment between COVID-19 infection and HSV infection based on the latest public health data and Genome-Wide Association Study (GWAS) data. Multiple causal estimation methods, such as IVW, weighted median, simple mode, and weighted mode, were employed to validate the causal relation between COVID-19 infection and HSV infection, with COVID-19 infection, COVID-19 hospitalization, and severe COVID-19 as exposures, and HSV1/2 infection as the outcome. A reverse MR analysis was subsequently performed. MR analysis exhibited that COVID-19 infection was relevant to a reduced risk of HSV1 infection (p=7.603239e-152, OR=0.5690, 95%CI=0.5455-0.5935, IVW). Regarding the effect of COVID-19 infection on HSV2, MR analysis suggested that COVID-19 infection was correlated with an augmented risk of HSV2 infection (p=6.46735e-11, OR=1.1137, 95%CI=1.0782-1.1502, IVW). The reverse MR analysis did not demonstrate a reverse causal relationship between HSV and COVID-19. Altogether, COVID-19 infection might cause a decreased risk of HSV1 infection and an elevated risk of HSV2 infection.

Identifiants

pubmed: 38146366
doi: 10.3389/fimmu.2023.1281292
pmc: PMC10749317
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1281292

Informations de copyright

Copyright © 2023 Yan, Xiao, Gosau, Friedrich, Smeets, Fu, Feng and Burg.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Ming Yan (M)

Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Li-Yuan Xiao (LY)

Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.

Martin Gosau (M)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Reinhard E Friedrich (RE)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ralf Smeets (R)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Ling-Ling Fu (LL)

Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hong-Chao Feng (HC)

Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.

Simon Burg (S)

Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Classifications MeSH